Month: December 2022

A transparent dressing inspired by duct tape has been shown to quickly heal internal injuries in rats. Leaks after gastrointestinal surgery can cause dangerous infections, affecting millions of people each year. Surgeons typically use stitches to help heal wounds, but these can form imperfect seals and heal abnormally, allowing bacteria from the gut to escape into nearby tissues. Now, Xuanhe Zhao at the Massachusetts Institute of Technology and his colleagues have designed a transparent, degradable dressing that helps gut wounds…

The announcement of a £1.8 million project by NICE and MHRA to review the regulation of mental health and wellbeing apps has prompted plans for a new trade body for developers of such apps, with an online launch meeting planned for 25th January 2023 at 10am. Behind the project is Chris Whitehouse, Med-Tech Innovation News columnist and director of medtech policy at Whitehouse Communications, who says: “It’s very early days, but already we’re in touch with MHRA and NICE, and…

Advantech, a medical computing platform service and solution provider, showcased its latest medical computer solutions for hospitals and the medical OEM industry at the MEDICA 2022 trade show. Visitors received live demonstrations within the specific applications inside hospitals and clinics, involving solutions for the digital operating room, patient rooms, nurse wards, critical care, and mobile care systems, amongst other medical environments. Advantech medical certified computing solutions are ready to implement for hospitals but also with strong customisation capabilities for the…

Digital health company Ada Health has announced that Ada Assess has successfully been certified as a Class IIa medical device under the European Union Medical Device Regulation (Regulation (EU) 2017/745) (EU-MDR). The EU-MDR is the medical device regulation applied by the European Commission. It was established to set EU-wide rules to improve the safety and quality of medical devices and provide transparency for patients to ensure public health and patient safety. The Ada Assess enterprise solution is among the first…

Roche has launched its next-generation portfolio SARS-CoV-2 rapid antigen tests (“2.0”) for self-testing and professional use in countries accepting the CE mark. In doing so, Roche builds upon its portfolio of COVID-19 rapid testing solutions with three new test configurations that feature an improved capture antibody and the addition of new digital data sharing capabilities to all tests. Using nasopharyngeal and nasal swab samples, respectively, the tests deliver results in as few as 15 minutes, aiding in the diagnosis of…